ReviewDiagnostics (Basel, Switzerland)2024
Prevention of Bacterial Infection in Biliary and Pancreatic Endoscopy-A Review.
Review in Diagnostics (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Evolving bile pathogen profiles and antimicrobial resistance in patients undergoing ERCP, with a focus on acute biliary pancreatitis: a 12-year retrospective study.BMC microbiology · 2026Article
- Infectious Complications and Safety Outcomes in Cholangioscopy: A Systematic Review and Meta-Analysis.Endoscopy international open · 2026Review
- Role of antibiotic prophylaxis in liver transplant patients undergoing endoscopic retrograde cholangiopancreatography: a systematic review and meta-analysis.EClinicalMedicine · 2025Article
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundEndoscopic retrograde cholangiopancreatography (ERCP) is a key therapeutic procedure in diseases of the pancreas or bile ducts. The understanding and effective management of the risks associated with the procedure, especially in the context of possible infectious complications, is crucial for patients' safety. The aim of this review was to analyze the results of studies on antibiotic prophylaxis for infectious complications of ERCP, pancreatoscopy, and cholangioscopy.
methodsThis study is a review of the articles available in PubMed, Medline, and Embase published in the last 30 years.
resultsNineteen studies and six sets of guidelines on antibiotic prophylaxis before ERCP were retrieved.
conclusionsBased on the available studies and recommendations, it can be concluded that antibiotic prophylaxis before ERCP is beneficial for immunocompromised patients or those at risk of bacterial endocarditis. In other groups of patients, antibiotic prophylaxis reduces the risk post-ERCP bacteremia but does not significantly reduce the risk of cholangitis and infectious complications. The effectiveness of antibiotic prophylaxis in patients at risk of incomplete biliary drainage needs to be verified in further studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.